Review



jurkat  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC jurkat
    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in <t>Jurkat</t> or <t>J.CaM1.6</t> cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.
    Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4633 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/pmc13755503-104-0-14
    Average 99 stars, based on 4633 article reviews
    jurkat - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "CHMP5 Is a TCR‐ and Interleukin‐7‐Regulated Protein Required for Naïve T Cell Homeostasis"

    Article Title: CHMP5 Is a TCR‐ and Interleukin‐7‐Regulated Protein Required for Naïve T Cell Homeostasis

    Journal: European Journal of Immunology

    doi: 10.1002/eji.70310

    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in Jurkat or J.CaM1.6 cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.
    Figure Legend Snippet: CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in Jurkat or J.CaM1.6 cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.

    Techniques Used: Western Blot, Expressing, Flow Cytometry, Control, Comparison, Fluorescence

    Related Articles

    other:

    Article Title: Aspartate inhibits mTORC1 activity and impairs reactivation of HIV-1 provirus.
    Article Snippet: Antibodies Rabbit polyclonal antiphospho-p70 S6K1 (T389) Cell Signaling Technology Cat #9205, RRID:AB_330944 Rabbit monoclonal anti-p70 S6K1 (49D7) Cell Signaling Technology Cat #2708, RRID:AB_390722 Rabbit monoclonal antiphospho-Akt (S473) (D9E) Cell Signaling Technology Cat #4060, RRID:AB_2315049 Rabbit monoclonal anti-Akt (pan) (C67E7) Cell Signaling Technology Cat #4691, RRID:AB_915783 Rat monoclonal antitubulin Abcam Cat #ab6160, RRID:AB_305328 Rabbit polyclonal anti-EAAT1 GeneTex Cat #GTX20262, RRID:AB_2887574 Goat polyclonal anti-rabbit IgG H&L (HRP) Abcam Cat #ab6721, RRID:AB_955447 Rabbit monoclonal anti-phospho-4E-BP1 (T37/46) (236B4) Cell Signaling Technology Cat #2855, RRID:AB_560835 Rabbit monoclonal anti-4E-BP1 (53H11) Cell Signaling Technology Cat #9644, RRID:AB_2097841 Rabbit polyclonal anti-HA Abcam Cat #ab9110, RRID:AB_307019 Bacterial and virus strains pMXS-SLC1A3 Birsoy et al. (45) Addgene #72873 pLKO.1 Stewart et al. (46) Addgene #8453 pHA-Raptor Jia et al. (47) Chemicals, peptides, and recombinant proteins Phorbol 12-myristate 13-acetate MilliporeSigma P1585 ADTBH Thermo Fisher Cat #H63716.06 ADEH Thermo Fisher Cat #J65983.06 L-aspartic acid MilliporeSigma Cat #A-6683 Puromycin BioBasic Cat #58-58-2 Rapamycin Cell Signaling Technology Cat #9904S Torin1 MilliporeSigma Cat #475991 L-glutamic acid MilliporeSigma Cat #G5889 L-arginine MilliporeSigma Cat #A5131 Protease inhibitor cocktail MilliporeSigma Cat #S8830 Phosphatase inhibitor cocktail Cell Signaling Technology Cat #5870 SuperSignal West Femto Maximum Sensitivity Substrate Thermo Fisher Cat #34095 Critical commercial assays Power SYBR Green RNA-to-CT 1-Step Kit (RT-PCR) Thermo Fisher Cat #4402955 Experimental models: cell lines Jurkat E6-1 ATCC Cat #TIB-152, RRID:CVCL_0367 HEK293 ATCC Cat #CRL-1573, RRID:CVCL_0045 HEK293T ATCC Cat #CRL-3216, RRID:CVCL_0063 Oligonucleotides RT-PCR forward for HIV-1 multiply spliced Tat-Rev: CTTAGGCATCTCCTATGGCAGGA Horvath and Sadowski (48) N/Aa RT-PCR reverse for HIV-1 multiply spliced Tat-Rev: GGATCTGTCTCTGTCTCTCTCTCCACC Horvath and Sadowski (48) N/A RT-PCR IL2 forward: AACTCACCAGGATGCTCACA Horvath and Sadowski (48) N/A RT-PCR IL2 reverse: GCACTTCCTCCAGAGGTTTGA Horvath and Sadowski (48) N/A (Continued on next page) Month XXXX Volume 0 Issue 0 10.1128/jvi.01426-2612 h ttp s: //j ou rn al s. as m .o rg /jo ur na l/j vi o n 07 N ov em be r 20 26 b y 10 3

    Article Title: Antigen-binding proteins and related methods of use
    Article Snippet: Large Scale Transfection of Antibodies Antibodies were expressed transiently using the Expi293 expression system (Life Technologies), and harvested on day 5.

    Cell Culture:

    Article Title: A structure-informed deep learning framework for modeling TCR-peptide-HLA interactions
    Article Snippet: .. Jurkat E6.1 (ATCC; TIB-152), HEK293T (ATCC; CRL-3216), and Plat-A (Cell Biolabs, San Diego, CA, USA; RV-102) cells were cultured at 37 °C and 5 % CO 2 . .. Jurkat E6.1 (ATCC; TIB-152), HEK293T (ATCC; CRL-3216), and Plat-A (Cell Biolabs, San Diego, CA, USA; RV-102) cells were cultured at 37 °C and 5 % CO 2 .



    Similar Products

    jurkat  (ATCC)
    99
    ATCC jurkat
    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in <t>Jurkat</t> or <t>J.CaM1.6</t> cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.
    Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/pmc13755503-104-0-14
    Average 99 stars, based on 1 article reviews
    jurkat - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC acute t cell leukemia
    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in <t>Jurkat</t> or <t>J.CaM1.6</t> cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.
    Acute T Cell Leukemia, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/pm42981192-239-9-15
    Average 99 stars, based on 1 article reviews
    acute t cell leukemia - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC jurkat cells
    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in <t>Jurkat</t> or <t>J.CaM1.6</t> cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.
    Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/bio_rxiv__64898__2026__11__03__763484-211-0-2
    Average 99 stars, based on 1 article reviews
    jurkat cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC human cancer cell lines jurkat
    A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon <t>Nalm6</t> cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of <t>SPARC-Jurkat</t> cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).
    Human Cancer Cell Lines Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/bio_rxiv__64898__2026__11__02__763574-159-0-11
    Average 99 stars, based on 1 article reviews
    human cancer cell lines jurkat - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC jurkat e6 1
    A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon <t>Nalm6</t> cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of <t>SPARC-Jurkat</t> cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).
    Jurkat E6 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/pm42969338-207-210-212
    Average 99 stars, based on 1 article reviews
    jurkat e6 1 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC jurkat clone e6 1
    A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon <t>Nalm6</t> cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of <t>SPARC-Jurkat</t> cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).
    Jurkat Clone E6 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/10__1016_slash_j__jcyt__2026__103058-61-0-4
    Average 99 stars, based on 1 article reviews
    jurkat clone e6 1 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC human t cell lines cem12d7
    A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon <t>Nalm6</t> cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of <t>SPARC-Jurkat</t> cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).
    Human T Cell Lines Cem12d7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jurkat+e6+1/Jurkat%2C+Clone+E6-1/pm42954482-288-0-7
    Average 99 stars, based on 1 article reviews
    human t cell lines cem12d7 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in Jurkat or J.CaM1.6 cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.

    Journal: European Journal of Immunology

    Article Title: CHMP5 Is a TCR‐ and Interleukin‐7‐Regulated Protein Required for Naïve T Cell Homeostasis

    doi: 10.1002/eji.70310

    Figure Lengend Snippet: CHMP5 is upregulated by TCR and IL‐7 and prevents naïve T cell apoptosis. (A) Western blot of CHMP5 protein in naïve CD4 + or CD8 + T cells stimulated by anti‐CD3ε crosslinking or cytokines IL‐2 and IL‐7 for 18 h. Data are representative of 3 independent experiments. (B) Western blot of CHMP5 protein induction kinetics in Jurkat or J.CaM1.6 cells activated by anti‐CD3 antibody over 8 h. Data are representative of 3 independent experiments. (C) Real‐time qPCR of Chmp5 mRNA expression (relative to Actb ) in the naïve CD4 + and CD8 + T cells shown in panel (A). (D) Western blot of FLAG‐CHMP5 protein induction in Jurkat cells treated with vehicle (DMSO) or the protein synthesis inhibitor cycloheximide (CHX). Data are representative of three independent experiments. (E, F) Representative flow cytometry plots of tdTomato and GFP expression (E) and Chmp5 transcripts (relative to Actb ) in CD4 + and CD8 + T cells flow cytometry‐sorted (as shown in gates) from R26 mTmG/CreERT2 Chmp5 fl/fl or control R26 mTmG/+ Chmp5 fl/fl mice following 4‐hydroxytamoxifen treatment for 72 h. (G) Frequency of Annexin‐V + CD4 + and CD8 + T cells following tamoxifen treatment. Each data point in (F) and (G) represents cells from a single mouse. One‐way ANOVA with Tukey's multiple comparison test: ns, not significant; * p < 0.05; ** p < 0.01; p < 0.01; *** p < 0.001. (H) Geometric mean fluorescence intensity (MFI) of surface IL‐7Rα expression on the indicated tdTomato and GFP fractions of T cells untreated (UT) or treated with IL‐7 for 18 h at 37°C. (I, J) MFI of surface TCRβ (I) and CD69 (J) expression on T cell subsets untreated (UT) or treated overnight with anti‐CD3 crosslinking antibody (xCD3). Data are representative of three independent experiments. Two‐way ANOVA with Tukey's multiple comparisons test: ns, not significant; * p < 0.05.

    Article Snippet: Jurkat (#TIB‐152) and the mutant Jurkat line J.CaM1.6 (#CRL‐2063) [ ] were purchased from ATCC (Manassas, VA) and maintained in complete RPMI.

    Techniques: Western Blot, Expressing, Flow Cytometry, Control, Comparison, Fluorescence

    A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of SPARC-Jurkat cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

    Journal: bioRxiv

    Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

    doi: 10.64898/2026.11.02.763574

    Figure Lengend Snippet: A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of SPARC-Jurkat cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

    Article Snippet: Human cancer cell lines Jurkat, Nalm6 and Raji were obtained from ATCC.

    Techniques: Mutagenesis, Expressing, Flow Cytometry, Two Tailed Test